Disappearing Prescriptions: China Corruption Campaign Prompts Physician Caution
Costly Cancer Drug Use Under Scrutiny
Executive Summary
While there are already restrictions on the prescribing of cancer drugs in China, oncologists in the world’s second-largest pharma market are also now being expected to strictly avoid off-label use, especially of costly imported therapies from multinationals.